TJ Jia

BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data.

Functions as a College/University

Functions as a College/University

HHLR is a long-term investor that invests in high-quality businesses across Asia and the world.

Octagon seeks to provide attractive risk-adjusted returns by investing in healthcare companies with long-term compounding growth potentials on behalf of clients. Clients typically invest in securities and financial instruments of companies in the healthcare sector globally, with focuses in companies headquartered in the US, China, the European Union, and the UK. They employ a bottom-up, fundamental company analysis when selecting client investments.

Develops novel oncology therapies

Develops ocular gene therapy

Develops therapeutics treatments for viral and liver diseases

Octagon Capital invests invests in both public and private companies across the globe. The firm targets companies operating in the fields of technology sectors and industries. It provides financing for early and buyout stage capital requirements.